Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0150
+0.0050 (50.00%)
Apr 29, 2026, 10:55 AM EST

Nu-Med Plus Statistics

Total Valuation

Nu-Med Plus has a market cap or net worth of 835,485. The enterprise value is 1.05 million.

Market Cap 835,485
Enterprise Value 1.05M

Important Dates

The next estimated earnings date is Monday, May 11, 2026.

Earnings Date May 11, 2026
Ex-Dividend Date n/a

Share Statistics

Nu-Med Plus has 83.55 million shares outstanding.

Current Share Class 83.55M
Shares Outstanding 83.55M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 45.04%
Owned by Institutions (%) n/a
Float 45.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio -3.08
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -18.64
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6.77

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -354.05%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 18.05%
Weighted Average Cost of Capital (WACC) -8.97%
Revenue Per Employee n/a
Profits Per Employee -28,091
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.00% in the last 52 weeks. The beta is -2.94, so Nu-Med Plus's price volatility has been lower than the market average.

Beta (5Y) -2.94
52-Week Price Change -80.00%
50-Day Moving Average 0.03
200-Day Moving Average 0.04
Relative Strength Index (RSI) 33.55
Average Volume (20 Days) 48,796

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.53

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -48,955
Pretax Income -56,182
Net Income -56,182
EBITDA n/a
EBIT -48,955
Earnings Per Share (EPS) -0.00
Full Income Statement

Balance Sheet

The company has 661 in cash and 212,500 in debt, giving a net cash position of -211,839 or -0.00 per share.

Cash & Cash Equivalents 661
Total Debt 212,500
Net Cash -211,839
Net Cash Per Share -0.00
Equity (Book Value) -271,278
Book Value Per Share -0.00
Working Capital -271,278
Full Balance Sheet

Cash Flow

Operating Cash Flow -47,979
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing 46,267
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Nu-Med Plus does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -6.72%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1